Is the developmentally immature immune response in paediatric sepsis a recapitulation of immune tolerance?

Immunology

Volumn 145, Issue 1, 2015, Pages 1-10

  Maddux, Aline B ^a   Douglas, Ivor S ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Endotoxin tolerance; Immune maturation; Immune tolerance; Neonatal sepsis; Paediatric sepsis

Indexed keywords

ENDOTOXIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; CELL INTERACTION; CHILDHOOD DISEASE; CROSS TOLERANCE; CYTOKINE PRODUCTION; HUMAN; IMMATURITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; CHILD; CHILD DEVELOPMENT; FEMALE; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD;

CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNE TOLERANCE; INFANT; MALE; SEPSIS;

EID: 84927651987     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12454     Document Type: Review

References (47)

1. Wiersinga WJ, Leopold SJ, Cranendonk DR, van der Poll T. Host innate immune responses to sepsis. Virulence 2014; 5:36-44.
2. Lopez-Collazo E, Del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care 2013; 17:242.
3. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med 2013; 14:686-93.
4. Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr 2012; 101:120-7.
5. Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infants, children, and adolescents. Virulence 2014; 5:179-89.
6. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-84.
7. Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med 2000; 343:338-44.
8. Medvedev AE, Sabroe I, Hasday JD, Vogel SN. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J Endotoxin Res 2006; 12:133-50.
9. Remington J, Klein JO, Wilson CB, Baker CJ. Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection. Infectious Diseases of the Fetus and Newborn Infant, 6th edn. Philadelphia, PA: Elsevier Saunders, 2006.
10. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004; 4:553-64.
11. Christaki E, Giamarellos-Bourboulis EJ. The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host. Virulence 2014; 5:57-65.
12. Diesner SC, Forster-Waldl E, Olivera A, Pollak A, Jensen-Jarolim E, Untersmayr E. Perspectives on immunomodulation early in life. Pediatr Allergy Immunol 2012; 23:210-23.
13. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 2005; 11:113-6.
14. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-α induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004; 173:4627-34.
15. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence 2014; 5:4-11.
16. Schaub B, Liu J, Schleich I, Hoppler S, Sattler C, von Mutius E. Impairment of T helper and T regulatory cell responses at birth. Allergy 2008; 63:1438-47.
17. Striz I, Brabcova E, Kolesar L, Sekerkova A. Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci (Lond) 2014; 126:593-612.
18. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7:379-90.
19. Kollmann TR, Crabtree J, Rein-Weston A et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009; 183:7150-60.
20. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012; 37:771-83.
21. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J Endotoxin Res 2004; 10:71-84.
22. Sadeghi K, Berger A, Langgartner M et al. Immaturity of infection control in preterm and term newborns is associated with impaired toll-like receptor signaling. J Infect Dis 2007; 195:296-302.
23. Yan SR, Qing G, Byers DM, Stadnyk AW, Al-Hertani W, Bortolussi R. Role of MyD88 in diminished tumor necrosis factor α production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004; 72:1223-9.
24. Sherrid AM, Kollmann TR. Age-dependent differences in systemic and cell-autonomous immunity to L. monocytogenes. Clin Dev Immunol 2013; 2013:917198.
25. Stasia MJ, Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008; 30:209-35.
26. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR. The adenosine system selectively inhibits TLR-mediated TNF-α production in the human newborn. J Immunol 2006; 177:1956-66.
27. Dijkstra KK, Hoeks SB, Prakken BJ, de Roock S. TH17 differentiation capacity develops within the first 3 months of life. J Allergy Clin Immunol 2014; 133:891-4 e5.
28. Shah BA, Padbury JF. Neonatal sepsis: an old problem with new insights. Virulence 2014; 5:170-8.
29. Lavoie PM, Huang Q, Jolette E et al. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J Infect Dis 2010; 202:1754-63.
30. Tulic MK, Andrews D, Crook ML, Charles A, Tourigny MR, Moqbel R, Prescott SL et al. Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J Allergy Clin Immunol 2012; 129:199-206 e1-4.
31. Pettengill MA, van Haren SD, Levy O. Soluble mediators regulating immunity in early life. Front Immunol 2014; 5:457.
32. Smith NL, Wissink E, Wang J, Pinello JF, Davenport MP, Grimson A, Rudd BD. Rapid proliferation and differentiation impairs the development of memory CD8+ T cells in early life. J Immunol 2014; 193:177-84.
33. Langrish CL, Buddle JC, Thrasher AJ, Goldblatt D. Neonatal dendritic cells are intrinsically biased against Th-1 immune responses. Clin Exp Immunol 2002; 128:118-23.
34. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006; 10:233.
35. Bluestone JA. Mechanisms of tolerance. Immunol Rev 2011; 241:5-19.
36. Ariga SK, Abatepaulo FB, Melo ES, Velasco IT, Pinheiro da Silva F, de Lima TM, Soriano FG. Endotoxin tolerance drives neutrophil to infectious site. Shock 2014; 42:168-73.
37. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med 2002; 30(Suppl):S64-73.
38. Cornell TT, Sun L, Hall MW, Gurney JG, Ashbrook MJ, Ohye RG, Shanley TP. Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2012; 143:1160-6 e1.
39. Frazier WJ, Hall MW. Immunoparalysis and adverse outcomes from critical illness. Pediatr Clin North Am 2008; 55:647-68, xi.
40. Hall MW, Geyer SM, Guo CY, et al. Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med 2013; 41:224-36.
41. Mella C, Suarez-Arrabal MC, Lopez S, Stephens J, Fernandez S, Hall MW, Mejias A. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis 2013; 207:564-73.
42. Muszynski JA, Nofziger R, Greathouse K et al. Innate immune function predicts the development of nosocomial infection in critically injured children. Shock 2014; 42:313-21.
43. Muszynski JA, Nofziger R, Greathouse K et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care 2014b; 18:R145.
44. Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 2014; 5:45-56.
45. Gomez HG, Gonzalez SM, Londono JM et al. Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study*. Crit Care Med 2014; 42:771-80.
46. Hynninen M, Pettila V, Takkunen O, Orko R, Jansson SE, Kuusela P, Renkonen R, Valtonen M. Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and -10 levels in critically ill patients with sepsis. Shock 2003; 20:1-4.
47. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, Vanhems P, Monneret G. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med 2010; 36:1859-66.